Details for New Drug Application (NDA): 050788
✉ Email this page to a colleague
The generic ingredient in CENTANY is mupirocin. There are sixteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
Summary for 050788
Tradename: | CENTANY |
Applicant: | Padagis Us |
Ingredient: | mupirocin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050788
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | 2% | ||||
Approval Date: | Dec 4, 2002 | TE: | BX | RLD: | No |
Expired US Patents for NDA 050788
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Padagis Us | CENTANY | mupirocin | OINTMENT;TOPICAL | 050788-001 | Dec 4, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription